Moxifloxacin Sandoz (Moxifloxacin)

Moxifloxacin is a fluoroquinolone antibiotic that targets bacterial DNA replication in various respiratory and skin infections.

• Community‑acquired bacterial pneumonia: eradicates the causative pathogens, leading to clinical improvement and resolution of infection.
• Acute bacterial sinusitis: reduces bacterial load, alleviating sinus inflammation and symptoms.
• Acute bacterial exacerbation of chronic bronchitis: controls infection, helping to restore airway function and reduce exacerbation severity.
• Skin and soft‑tissue infections: eliminates susceptible bacteria, promoting healing of infected skin lesions.

• Moxifloxacin exerts its antibacterial effect by binding to the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV. Inhibition of these enzymes prevents the supercoiling and separation of DNA strands required for replication and transcription, leading to bacterial cell death. This dual targeting enhances activity against a broad spectrum of Gram‑positive and Gram‑negative organisms. The drug penetrates respiratory tissues and skin, achieving concentrations sufficient for bacterial kill.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset often transient.
• Diarrhea: loose stools that may be self‑limiting.
• Headache: mild to moderate head pain.
• Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or rupture, especially in the Achilles.
• QT interval prolongation: cardiac rhythm changes that can lead to arrhythmia.
• Severe allergic reactions: rash, swelling, or anaphylaxis.
• Clostridioides difficile colitis: severe intestinal infection with diarrhea.

Before prescribing Moxifloxacin, clinicians should consider several safety precautions to minimize risk.

• Renal or hepatic impairment: adjust therapy based on function and monitor.
• History of tendon disorders: avoid use in patients with prior tendon injury or recent corticosteroid therapy.
• Cardiac risk factors: assess QT prolongation risk, especially with electrolyte abnormalities.
• Pregnancy and breastfeeding: use only if clearly needed, as safety data are limited.
• Store below 25°C: keep in the original packaging, protect from moisture and light.

Moxifloxacin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce absorption; separate dosing by at least 2 hours.
• Class Ia antiarrhythmics (e.g., quinidine): may cause significant QT prolongation.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect; monitor INR.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of CNS stimulation and seizures.
• Theophylline: may increase serum levels; monitor for toxicity.